Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytotoxic Drug”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00001096
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Looking for participantsNCT02912897
What this trial is testing

Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy with Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients with a First Clinical Episode Highly Suggestive of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Nantes University Hospital 7
Not applicableNot Yet RecruitingNCT07014904
What this trial is testing

"Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"

Who this might be right for
ITP - Immune Thrombocytopenia
Sohag University 80
Early research (Phase 1)Active Not RecruitingNCT01861314
What this trial is testing

Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Post Cytotoxic TherapyRecurrent Adult Acute Myeloid Leukemia+1 more
National Cancer Institute (NCI) 15
Early research (Phase 1)WithdrawnNCT00866346
What this trial is testing

PR1-Specific Cytotoxic T-Lymphocyte Infusion With Recurrent Chronic Myelogenous Leukemia (CML) After Allogeneic Hematopoietic Transplantation

Who this might be right for
Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03789617
What this trial is testing

A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies

Who this might be right for
EBV Associated Extranodal NK/T-cell LymphomaEBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma
Eutilex 72
Early research (Phase 1)Looking for participantsNCT04180059
What this trial is testing

Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation

Who this might be right for
Haematologic Disease
Nantes University Hospital 6
Early research (Phase 1)UnknownNCT04193098
What this trial is testing

Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLC

Who this might be right for
Non-small Cell Lung CancerSecond-line Treatment
Tianjin Medical University Cancer Institute and Hospital 10
Early research (Phase 1)WithdrawnNCT02598687
What this trial is testing

Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.

Who this might be right for
Esophageal Cancer
Maastricht Radiation Oncology
Not applicableLooking for participantsNCT05014399
What this trial is testing

Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy

Who this might be right for
Neoplasm, ColorectalCognitive ImpairmentCognitive Dysfunction+5 more
Joseph McCollom 60
Testing effectiveness (Phase 2)Study completedNCT01213407
What this trial is testing

Dendritic Cell Cancer Vaccine for High-grade Glioma

Who this might be right for
Glioblastoma Multiforme
Activartis Biotech 87
Testing effectiveness (Phase 2)Active Not RecruitingNCT03953898
What this trial is testing

Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia Post Cytotoxic Therapy+4 more
National Cancer Institute (NCI) 14
Early research (Phase 1)UnknownNCT00006100
What this trial is testing

Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Milton S. Hershey Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT03362606
What this trial is testing

Engineered Immune Effectors Against Ovarian Cancer

Who this might be right for
Ovarian Cancer
Shenzhen Geno-Immune Medical Institute 20
Early research (Phase 1)Ended earlyNCT02381548
What this trial is testing

Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Post Cytotoxic TherapyBlast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive+6 more
National Cancer Institute (NCI) 20
Very early researchLooking for participantsNCT07434284
What this trial is testing

Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies

Who this might be right for
Advanced Gynecological Cancers
Obstetrics & Gynecology Hospital of Fudan University 20
Early research (Phase 1)UnknownNCT01637805
What this trial is testing

Clinical Safety and Preliminary Efficacy of AAV-DC-CTL Treatment in Stage IV Gastric Cancer

Who this might be right for
Stage IV Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Post-approval studies (Phase 4)Ended earlyNCT03858166
What this trial is testing

Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer

Who this might be right for
Adjuvant ChemotherapyOvarian NeoplasmsOvarian Cancer
Shandong University 68
Testing effectiveness (Phase 2)Ended earlyNCT02808247
What this trial is testing

Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
European Organisation for Research and Treatment of Cancer - EORTC 80
Early research (Phase 1)Looking for participantsNCT05142189
What this trial is testing

Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BioNTech SE 320
Next Page